🇪🇺 BREXUCABTAGENE AUTOLEUCEL in European Union

BREXUCABTAGENE AUTOLEUCEL (BREXUCABTAGENE AUTOLEUCEL) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/005102
  • Local brand name: Tecartus
  • Status: approved

BREXUCABTAGENE AUTOLEUCEL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BREXUCABTAGENE AUTOLEUCEL approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for BREXUCABTAGENE AUTOLEUCEL in European Union?

Marketing authorisation holder not available in our data.